Celldex Therapeutics Inc Capital Reinvestment Ratio
Celldex Therapeutics Inc capital reinvestment ratio. Celldex Therapeutics Inc (CLDX) has a Capital Reinvestment Ratio of 0.02x as of December 2008, meaning it reinvests 0% of its operating cash flow ($1.29 Million) in capital expenditures ($26.75K). Check Celldex Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Celldex Therapeutics Inc (2006–2008)
Capital reinvestment ratio of Celldex Therapeutics Inc from 2006 to 2008. This chart tracks Celldex Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore Celldex Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Celldex Therapeutics Inc Capital Reinvestment Ratio by Year (2006–2008)
Celldex Therapeutics Inc capital reinvestment ratio by year from 2006 to 2008. For the full cash flow conversion analysis, see Celldex Therapeutics Inc (CLDX) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.07x | $18.28 Million | $1.30 Million | ▼ -79.3% |
| 2006 | 0.35x | $27.00 Million | $9.32 Million | — |